Skip to main content
Premium Trial:

Request an Annual Quote

AxCell, University of Muenster To Study Neurodegenerative Proteins

NEW YORK, April 24-Cytogen subsidiary AxCell Biosciences said today that it will partner with researchers at the University of Muenster to research proteins involved in neurodegenerative disease.

 

AxCell will provide data from its signal transduction database, and the research will seek to understand the signaling pathway of a neuronal protein thought to be involved in degenerative disorders and Alzheimer's disease.

 

Under the deal, discoveries will be the joint property of the university and the company. AxCell retains an option to negotiate an exclusive, worldwide, royalty-bearing license from the university for any discoveries.

 

AxCell did not name the gene that would be the focus of this research, but said that the work would be led by Joachim Kremerskothen and Angelika Barnelow, who study neuronal proteins produced by dendritic-localized mRNAs. Normal transcription of dendritic mRNA, said the company, is essential for learning and memory.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.